Johnston S - Search Results

1

Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial.

Krop IE, Mayer IA, Ganju V, Dickler M, Johnston S, Morales S, Yardley DA, Melichar B, Forero-Torres A, Lee SC, de Boer R, Petrakova K, Vallentin S, Perez EA, Piccart M, Ellis M, Winer E, Gendreau S, Derynck M, Lackner M, Levy G, Qiu J, He J, Schmid P. Krop IE, et al. Among authors: johnston s. Lancet Oncol. 2016 Jun;17(6):811-821. doi: 10.1016/S1470-2045(16)00106-6. Epub 2016 May 4. Lancet Oncol. 2016. PMID: 27155741 Free PMC article. Clinical Trial.

2

Towards a molecular basis for tamoxifen resistance in breast cancer.

Johnston SR, Dowsett M, Smith IE. Johnston SR, et al. Ann Oncol. 1992 Jul;3(7):503-11. doi: 10.1093/oxfordjournals.annonc.a058251. Ann Oncol. 1992. PMID: 1498070 Free article. Review.

3

Modulation of Bcl-2 and Ki-67 expression in oestrogen receptor-positive human breast cancer by tamoxifen.

Johnston SR, MacLennan KA, Sacks NP, Salter J, Smith IE, Dowsett M. Johnston SR, et al. Eur J Cancer. 1994;30A(11):1663-9. doi: 10.1016/0959-8049(94)00327-2. Eur J Cancer. 1994. PMID: 7833141

4

Detection of wild type and exon 5-deleted splice variant oestrogen receptor (ER) mRNA in ER-positive and -negative breast cancer cell lines by reverse transcription/polymerase chain reaction.

Daffada AA, Johnston SR, Nicholls J, Dowsett M. Daffada AA, et al. Among authors: johnston sr. J Mol Endocrinol. 1994 Dec;13(3):265-73. doi: 10.1677/jme.0.0130265. J Mol Endocrinol. 1994. PMID: 7893344

5

Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentration.

Johnston SR, Haynes BP, Smith IE, Jarman M, Sacks NP, Ebbs SR, Dowsett M. Johnston SR, et al. Lancet. 1993 Dec 18-25;342(8886-8887):1521-2. doi: 10.1016/s0140-6736(05)80088-1. Lancet. 1993. PMID: 7902904

6

Clinical and endocrine effects of the oral aromatase inhibitor vorozole in postmenopausal patients with advanced breast cancer.

Johnston SR, Smith IE, Doody D, Jacobs S, Robertshaw H, Dowsett M. Johnston SR, et al. Cancer Res. 1994 Nov 15;54(22):5875-81. Cancer Res. 1994. PMID: 7954417 Clinical Trial.

7

The novel anti-oestrogen idoxifene inhibits the growth of human MCF-7 breast cancer xenografts and reduces the frequency of acquired anti-oestrogen resistance.

Johnston SR, Riddler S, Haynes BP, A'Hern R, Smith IE, Jarman M, Dowsett M. Johnston SR, et al. Br J Cancer. 1997;75(6):804-9. doi: 10.1038/bjc.1997.144. Br J Cancer. 1997. PMID: 9062399 Free PMC article.

8

Oestrogen receptor mutants and variants in breast cancer.

Dowsett M, Daffada A, Chan CM, Johnston SR. Dowsett M, et al. Among authors: johnston sr. Eur J Cancer. 1997 Jul;33(8):1177-83. doi: 10.1016/s0959-8049(97)00100-7. Eur J Cancer. 1997. PMID: 9301439 Review.

9

Clinical studies of apoptosis and proliferation in breast cancer.

Dowsett M, Archer C, Assersohn L, Gregory RK, Ellis PA, Salter J, Chang J, Mainwaring P, Boeddinghaus I, Johnston SR, Powles TJ, Smith IE. Dowsett M, et al. Among authors: johnston sr. Endocr Relat Cancer. 1999 Mar;6(1):25-8. doi: 10.1677/erc.0.0060025. Endocr Relat Cancer. 1999. PMID: 10732783 Review.

10

Low-dose oral fluorouracil with eniluracil as first-line chemotherapy against advanced breast cancer: a phase II study.

Smith IE, Johnston SR, O'Brien ME, Hickish TF, de Boer RH, Norton A, Cirkel DT, Barton CM. Smith IE, et al. Among authors: johnston sr. J Clin Oncol. 2000 Jun;18(12):2378-84. doi: 10.1200/JCO.2000.18.12.2378. J Clin Oncol. 2000. PMID: 10856097 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,388 results

Search Page

Filters